Introduction 1). [1] [2] [3] [4] Rheumatoid arthritis (RA) is a systemic autoimmune disOne difficulty with using proteins as therapeutic ease characterized by chronic inflammation of the joints. agents for RA is the inability to deliver the protein to the The onset of RA is insidious, but its course is progressive.
site where the disease is manifested, the joint. This probThe synovium, normally a thin tissue which lines the lem of protein delivery can be circumvented by transfer interior surfaces of the joint capsule, becomes massively of genes encoding therapeutic proteins to the synovial thickened from synovial cell proliferation, leukocytic lining of the joint capsule. 5, 6 Overexpression of the infiltration and excessive matrix deposition. The secreted gene products into the joint space and articular hypertrophied synovium that lies adjacent to the articular tissues would thereby provide the highest concentration cartilage develops into an invasive structure, called of therapy at the site of disease. Initial experiments pannus. Possessing an aggressive phenotype, this tissue involving gene transfer to the joint were conducted using invades and erodes the articular cartilage and subchondan ex vivo approach, where synovial cells were surgically ral bone. Over time, the degradation may cause complete removed from joints, cultured in vitro, transduced with joint failure which is treatable only by prosthetic replaceamphotropic retroviruses and reimplanted into the ment.
respective donors by intraarticular injection. 7 When this The precise mechanism which initiates the progression technique was used to deliver the human interleukin-1 of RA remains poorly understood. Current evidence sugreceptor antagonist gene to the knees of animals with gests that both genetic and environmental factors may experimental arthritis, significant improvements were contribute to the etiology of RA. Currently, a variety of noted in many of the pathogenic effects of the animal pharmacological agents are being used to manage dismodels. 8, 9 The success of these results has recently led to ease; however, no combination of conventional treatthe implementation of a phase I clinical trial to test the ments has proved effective in halting disease progression.
safety and efficacy of using gene therapy to treat RA.
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Recently certain biological agents have been shown to The ex vivo gene delivery approach, while effective, is suppress certain RA-associated pathologies. Among the invasive, tedious, labor intensive and expensive, which most promising therapeutic proteins are those which severely limits its practical application. The direct delivinhibit the activity of proinflammatory cytokines such as ery of gene transfer vectors to the joint in situ would alleviate some of the problems associated with the ex vivo method; indeed, experiments with adenoviral vectors associated with expression of endogenous viral proteins induces a moderate to severe monoarticular synovitis with synovial hypertrophy, hyperplasia and leukocytic by transduced cells, 14 an obviously undesirable consequence in an arthritic joint. Direct gene transfer in vivo infiltration. The inflammation persists for approximately 10 to 14 days after which hIL-1␤ gene expression is lost, using retroviral vectors, which express no viral protein, would minimize complications due to virus-induced and the condition rapidly resolves. 17 Twenty-four hours after implantation of the hIL-1␤+ inflammation or specific immune responses. Although Moloney murine leukemia virus (MoMLV)-based retrovicells, approximately 7 × 10 7 c.f.u. of the N2-␤-gal retrovirus were injected through the patellar tendon into both ral vectors 15, 16 require active cell division for successful integration and expression of the vector genome, the synknees of three of the rabbits. As a control, the fourth rabbit was injected with saline. Seven days later, the rabbits ovial cell proliferation associated with synovitis and early pannus formation in developing RA may provide an were killed, the knees dissected, and frozen sections stained for lacZ activity. Analyses of the synovium of the environment suitable for efficient retroviral transduction in vivo.
non-hIL-1␤ expressing knees (non-inflamed joints) which had received the N2-␤-gal virus revealed lacZ+ cells in We have recently reported the use of gene transfer to the joints of rabbits as a means to analyze the effects of scattered sites in the outermost layer of the synovial lining, about two to three per high powered field (Figure chronic exposure to individual arthritis-associated proteins. 17 Ex vivo delivery of the human IL-␤ gene to the 2a and b). In vivo retroviral transduction of inflamed knees resulted in a higher number of regions expressing joints of rabbits was found to produce all the major pathologies of RA, including synovial hypertrophy and the lacZ gene, although variable, generally about five to 10 per high-powered field (Figure 2c and d). Whereas hyperplasia, cartilage degradation, and aggressive pannus formation. We have used this animal model to most of the lacZ+ cells in inflamed synovium were observed in the outermost layer of the lining, numerous test the feasibility of using retroviral vectors to deliver exogenous coding regions in vivo to inflamed or arthritic regions contained blue stained cells that were several layers deep within the synovial tissue. Furthermore, the lacZ joints. For these experiments we have employed the use of a high-titer N2-based retroviral vector carrying either staining in these areas appeared as clusters or foci of positively staining cells. In both inflamed and uninflamed the ␤-galactosidase (lacZ) or human growth hormone (hGH) marker genes. 18 Our results demonstrate that joints, lacZ+ cells were limited to cells in the synovial lining or the immediate subsynovium; no lacZ+ cells retroviral vectors are able to transduce stably the dividing synovial cells in an inflamed joint and achieve levels were observed outside this region. Tissue sections from inflamed and uninflamed joints that had not been of transgene expression similar to that using the ex vivo gene transfer method. These results suggest that retroviexposed to the N2-␤-gal retrovirus had no detectable lacZ activity (Figure 2e and f). Previous in vivo gene transfer ral vectors could be used for in vivo gene transfer to sites of inflammation such as the joints of RA patients.
experiments conducted by injecting amphotropic retroviral preparations with considerably lower titers (Ͻ10 6 c.f.u./ml) into uninflamed knees had consistently
Results
resulted in undetectable levels of transgene expression. However, the results obtained here with higher titer virus The retroviral vectors used for this study ( Figure 1) were stocks demonstrate that retrovirus-mediated delivery of derived from an N2-based backbone. 18 The MoMLV LTR exogenous genes to synovial tissue in vivo is in fact possis used to drive the gene of interest whereas a downible and may be greater in inflamed joint tissue. stream SV40 promoter is responsible for expression of the Having demonstrated that the high-titer retroviral neomycin phosophotransferase (neo r ) gene. A high-titer stocks could transduce a substantial number of cells of stock (Ͼ10 8 /ml) of each virus was prepared from the canthe synovial lining in situ both in naive and inflamed ine amphotropic producer line D2. We initially evaluated joints, we wanted to compare transgene expression and compared the ability of the N2-␤-gal retroviral vector obtained by in vivo gene delivery with that of the ex vivo to directly transduce naive and inflamed synovium in the method. To compare quantitatively the two methods, the rabbit knee joint. Staining tissue sections for lacZ activity second retroviral construct N2-hGH was employed would thereby allow localization of any transduced cells.
which encoded a secreted protein whose expression To achieve a sustained inflammatory environment in the could be determined by ELISA measurements of both joint, four rabbits were injected in the left knee with culture supernatants and lavage fluids recovered from 2 × 10 6 cells of a lapine synovial fibroblast line, HIG-82, 19 the knee joints. transduced with a retrovirus (DFG-hIL-1␤-neo) encoding
To compare hGH transgene expression levels in naive human interleukin-1␤ (hIL-1␤). This procedure rapidly knees, 3 × 10 6 HIG-82 cells were first transduced in vitro with 7 × 10 7 c.f.u. of the hGH retrovirus, and the transduced cultures expanded. ELISA measurements of culture supernatants detected greater than 210 ng of hGH per ml of medium per 10 6 cells/48 h. Approximately 1.5 × 10 7 of the HIG-82-hGH+ cultures were then injected into the joint capsule of one knee of three rabbits. Ex vivo ution at 3 and 7 days after transduction/transplant and 
u. of the N2-␤-gal retrovirus were injected intraarticularly into both knees of three rabbits. One rabbit was not exposed to the N2-␤-gal retrovirus. Seven days later, the rabbits were killed, the knees dissected, and frozen sections stained for lacZ activity. Uninflamed and inflamed synovial sections from the nontransduced rabbit joints were also stained for lacZ activity and are shown in (e) and (f), respectively. Original magnification × 100 (a, c, e, f) × 300 (b, d).
the level of hGH determined by ELISA. Consistent with solution and the recovered fluids analyzed for hGH expression. In contrast to the naive joints, inflamed knees the results described above with retrovirus encoding lacZ, a low level of hGH expression was detected in the receiving either allografted cells or retrovirus expressed the hGH transgene at approximately the same level at naive knees injected with the hGH retroviral particles which persisted for the length of the experiment ( Figure  day 3 and day 7, each generating approximately 1 ng per ml of recovered fluid (Figure 3b) . However, by day 14 in 3a). Ex vivo gene transfer into naive joints provided for considerably higher expression of the hGH transgene at vivo transduction had exceeded that of the ex vivo transfer and persisted for 28 days. In contrast, ex vivo transgene each time-point.
Similar to experiments with lacZ, we also compared expression had totally diminished by day 28. The duration of expression cannot be legitimately compared in levels of expression following gene transfer into joints inflamed by constitutive IL-1␤ transgene expression. these experiments, since the allogeneic HIG-82 cells are likely to be rejected by the recipient rabbits. However, Approximately 2 × 10 6 HIG-82-hIL-1␤+ cells were injected into both knee joints of three rabbits. Twentyrelative to ex vivo retrovirus-mediated gene delivery, in vivo transduction with adenovirus or herpes simplex four hours later, the N2-hGH retrovirus was injected into one knee, while 1.5 × 10 7 HIG-82 cells previously transvirus, or gene transfer via nonviral methods, the profile of hGH levels obtained following in vivo retrovirusduced with the hGH retrovirus were injected into the contralateral joint. At 3, 7, 14 and 28 days after mediated delivery represents the most stable, sustained intraarticular transgene expression observed to date, injection/transplant, the knees were lavaged with saline inflamed joints with proliferative synovitis than in normal joints. Since one of the primary symptoms of RA is the thickening of the synovium through synovial cell proliferation, these studies suggest that retroviral vectors may have an application in the delivery of genes to the joints of patients with developing RA or joints undergoing episodes of acute synovitis. Alternatively, synovial cell division could be provoked by, for example, the injection of growth factors shortly before the introduction of the retrovirus. These results are consistent with previous experiments demonstrating stable retroviral infection of inflamed synovium following the intraarticular implantation of xenogeneic retroviral producer cells into the ankle joints of rats with bacterial cell wall-induced arthritis. 20 However, in the previous experiments, no infection was observed by direct injection of retrovirus, and the use of xenotropic producer cells for gene delivery to joints is not suitable for clinical applications.
Relative to other gene transfer vehicles, there are clear potential benefits to in vivo gene delivery to the joint with retroviral vectors. First, unlike early generation adenoviral vectors, no retroviral proteins are encoded in the vector, eliminating inflammatory effects from the presentation of viral antigens in transduced cells. Thus, infected cells may not be targeted for clearance by the immune system. Second, since the retroviral sequences are integrated into the genome of the synovial cells, transgene expression may be more stable than other vector systems whose genetic material remains episomal. Moreover, as suggested by the foci of lacZ+ cells observed in inflamed knees in Figure 2b , transgene expression following retroviral delivery may actually be heightened by subsequent periods of synovial cell division.
Although the data reported here suggest that retroviral vectors may be an attractive vector for gene delivery to the inflamed joint, little is known however about the biology of the synoviocyte with respect to its use as a target cell for gene delivery. Experiments conducted in our laboratory involving ex vivo transfer with retrovirally For intraarticular transplantation, transduced cultures were treated with trypsin, washed, and resuspended in to be as efficient as ex vivo delivery, may be a feasible method for transferring genes to the joints of patients Gey's balanced salt solution (Gibco-BRL) to a final concentration of 2 × 10 7 cells per ml. Cell suspensions were with RA.
injected through the patellar tendon into the knee joints of recipient rabbits.
Materials and methods
For retroviral transduction in vivo, rabbit knees were first lavaged with 1 ml of saline containing 8 g/ml Retroviral vector and VPCL production polybrene; retrovirus in formulation buffer with 8 g/ml Briefly, the vectors used in this study are derived from polybrene was then injected into the joint space through an N2-based backbone in which the gag ATG initiator the patellar tendon. codon has been mutated to ATT by site-directed mutagenesis. 18 The MoMLV LTR is used to drive the Biological analyses gene of interest, and a downstream SV40 promoter is To lavage rabbit knee joints, 1 ml of Gey's balanced salt responsible for expression of the neo r gene. The N2-␤-gal solution plus 1 mm EDTA was injected into the joint vector has been previously described. 22 The N2-hGH vecspace through the patellar tendon. After manipulation of tor was generated by inserting the 800 bp hGH gene from the joint, the needle was reinserted and the fluid aspirMartial et al, 23 into the modified N2 backbone in place of ated. Human growth hormone concentrations in conthe ␤-gal gene.
ditioned media and lavage fluids were measured as The N2-␤-gal and N2-hGH constructs were individudirected using ELISA kits from Boehringer Mannheim, ally cotransfected with a construct encoding the vesicular Mannheim, Germany. stomatitis virus G (VSV G) glycoprotein (MLP-G) into the For histological analyses, tissues harvested from dishuman 293 gag-pol cell line. 24 Supernatants from this sected knees were embedded in Tissue-tek OCT comtransfection allowed transduction into the DA packaging pound (Miles, Elkhart. IN, USA) and snap frozen at cell line by pseudotyping the amphotropic murine leuke-−70°C. Tissues were sectioned frozen at 8 microns using mia virus particles with the VSG-G glycoprotein. The DA a cryostat. lacZ+ Cells were stained with 5-bromo cell line is an amphotropic 'split-genome' packaging cell -4-chloro-3-indolyl-␤-d-galactopyranoside (Boehringer line derived from the canine D-17 osteosarcoma (ATCC Mannheim, Indianapolis, IN, USA) by routine methods. 26 CRL 8468) cell line. After cloning by limiting dilution, G418-resistant DA clones were selected. These vector pro-
